FAP+ CAFs may be multifunctional mesenchymal stem cells that are recruited into the tumor environment, thus leading to the above malignant results; therefore, the direct inhibition of the FAP+ CAF strategy needs to be discussed (Tran et al., 2013). The gene discussed is FAP; the disease is neoplasm.